- Condition: Hepatitis C, Chronic
Interventions: Drug: ALS-002158; Drug: Placebo
Sponsors: Alios Biopharma Inc.; Alios Biopharma Inc.; Vertex Pharmaceuticals Incorporated
Recruiting - verified March 2012 - Conditions: Smoking; Addiction
Intervention: Drug: Nicabate 21mg Transdermal Nicotine Replacement Therapy (NRT)Patch
Sponsors: The Queen Elizabeth Hospital; The Queen Elizabeth Hospital; Basil Hetzel Institute for Translational Research; University of Adelaide; University of South Australia; Clinical Practice Unit; Therapeutics Research Centre
Recruiting - verified September 2011 - Conditions: Meningococcal Disease; Meningococcal Meningitis
Intervention: Biological: Serogroup B meningococcal vaccine
Sponsors: Novartis; Novartis; Novartis Vaccines
Completed - verified January 2012 - Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: GSK2018682; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Pain
Intervention:
Sponsors: IX Biopharma Pte. Ltd.; IX Biopharma Pte. Ltd.
Recruiting - verified June 2011 - Condition: Multiple Sclerosis
Interventions: Drug: GSK2018682; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012 - Condition: Influenza Infection
Intervention: Biological: GSK Biologicals' investigational vaccine GSK1562902A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified January 2012 - Conditions: Ulcerative Colitis; Crohn's Disease
Interventions: Drug: AMG 181; Other: Placebo for AMG 181
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Condition: Infections, Bacterial
Interventions: Drug: GSK2251052; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Crohn's Disease
Intervention: Drug: AMG 139
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Condition: Prophylaxis of Ross River Virus Infection
Intervention: Biological: Ross River Virus Vaccine
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Active, not recruiting - verified October 2011 - Conditions: Metabolic Syndrome; Diabetes
Intervention: Dietary Supplement: high fat overfeeding
Sponsors: University of Adelaide; University of Adelaide
Recruiting - verified October 2010 - Condition: Ulcerative Colitis
Intervention: Drug: Amg 181
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Conditions: Bacterial Infections; Staphylococcal Vaccines; Immunotherapy, Active; Staphylococcal Skin Infections; Staphylococcal Infections
Interventions: Biological: SA3Ag vaccine; Procedure: Blood draw; Procedure: Colonization swab samples; Biological: SA3Ag followed by Placebo; Procedure: Blood draw; Procedure: Colonization swab samples; Biological: Placebo; Procedure: Blood draw; Procedure: Colonization swab samples; Biological: SA3Ag with no booster in stage 2; Procedure: Blood draw; Procedure: Colonization swab samples; Procedure: Placebo with no booster in stage 2; Procedure: Blood draw; Procedure: Colonization swab samples
Sponsors: Pfizer; Pfizer
Completed - verified August 2011 - Condition: Contraception
Intervention: Drug: Ethinylestradiol/Gestodene (BAY86-5016)
Sponsors: Bayer; Bayer
Completed - verified October 2011 - Condition: Influenza
Interventions: Biological: CSL Limited Influenza Virus Vaccine; Biological: CSL Limited Influenza Virus Vaccine; Biological: CSL Limited Influenza Virus Vaccine
Sponsors: CSL Limited; CSL Limited
Completed - verified August 2011 - Condition: Meningitis, Meningococcal
Interventions: Biological: meningococcal B rLP2086 vaccine.; Biological: meningococcal B rLP2086 vaccine.; Biological: meningococcal B rLP2086 vaccine.; Other: normal saline (placebo)
Sponsors: Pfizer; Pfizer
Active, not recruiting - verified April 2012 - Condition: Osteonecrosis
Interventions: Drug: Zoledronic Acid; Drug: Placebo
Sponsors: University of Sydney; University of Sydney; Novartis
Recruiting - verified February 2011 - Conditions: Alzheimer Disease; Amyloid Beta-Protein
Intervention: Drug: Florbetaben (BAY94-9172)
Sponsors: Bayer; Bayer
Completed - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Escitalopram; Drug: Sertraline; Drug: Venlafaxine XR
Sponsors: BRC Operations Pty. Ltd.; BRC Operations Pty. Ltd.
Recruiting - verified March 2012 - Conditions: Respiratory Syncytial Virus (RSV); Parainfluenza Virus Type 3 (PIV3)
Interventions: Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534; Biological: Placebo
Sponsors: MedImmune LLC; MedImmune LLC
Active, not recruiting - verified May 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Influenza
Interventions: Biological: CSL Limited Influenza Vaccine; Biological: Placebo
Sponsors: CSL Limited; CSL Limited
Completed - verified August 2011 - Conditions: Healthy Subjects; Infections, Bacterial
Interventions: Drug: GSK945237; Drug: Sugar Pill
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified October 2011 - Condition: Locally Recurrent and Metastatic Breast Cancer
Interventions: Drug: AMG 386 Placebo; Drug: AMG 386; Drug: Bevacizumab; Drug: AMG 386; Drug: AMG 386; Drug: Paclitaxel
Sponsors: Amgen; Amgen
Active, not recruiting - verified September 2011 - Conditions: Gastroparesis; Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Sitagliptin
Sponsors: Royal Adelaide Hospital; Royal Adelaide Hospital; Merck
Active, not recruiting - verified August 2011 - Conditions: Healthy Subjects; Anaemia
Interventions: Drug: GSK626616, placebo, midazolam; Drug: omeprazole, caffeine, flurbiprofen, rosiglitazone
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2011 - Conditions: Hepatic Impairment; Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: eltrombopag
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012 - Conditions: Meningococcal Infection; Haemophilus Infection
Interventions: Biological: Haemophilus influenzae type b and meningococcal serogroup C (vaccine); Biological: Priorix™; Biological: Hiberix™; Biological: Meningitec™
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified September 2011 - Conditions: Hepatitis B; Hepatitis A
Interventions: Biological: Twinrix™ Adult; Biological: Twinrix™ Junior
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified November 2011 - Conditions: Human Papillomavirus (HPV) Infection; Cervical Neoplasia
Intervention: Biological: HPV-16/18 L1/AS04
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified March 2012 - Conditions: Human Papillomavirus (HPV) Infection; Cervical Neoplasia
Interventions: Biological: Cervarix™; Biological: Havrix™-based investigational formulation
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012


